NeoEA-1001

N/A

Report date: 2023/02/18 19:47:36
NME

Base Information

Drug NameNeoEA-1001
Drug Alias NameNeoEA-1001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNeocodex
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNeocodex
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A